Tag Archives: UNITAID

TB diagnostic tool development and access remain first obstacles to finding and treating tuberculosis where it poses greatest threats

By on .

In the obstacle course that detecting, treating and curing tuberculosis can present to populations most affected by the disease, the first hurdle, caused by gaps in technology appropriate to realities where the disease flourishes, remains diagnosis. In turn, obstacles to developing diagnostic tools and getting them on the ground, include lack of resources to test […]

Targeting the pediatric HIV treatment gap, speeding drug development, imagining a world of equitable treatment access, the Medicines Patent Pool aims for breakthroughs

By on .

An event last week launching the Pediatric treatment Initiative “to get kids the medicines they need,” included the news of a commitment to double the number of children on treatment with support from the President’s Emergency Plan For AIDS Relief within the next two years. With a continued gap that sees an estimated two million […]

Access to treatments for MDR TB, hepatitis C, other health threats set to expand with UNITAID grants targeting market barriers

By on .

The first new tuberculosis drug in more than 40 years, a treatment for hepatitis C currently priced in the United States at $84,000, and an early infant diagnostic test for HIV are among the breakthrough medicines and technologies the global health financing organization UNITAID is aiming to make available to people in low- and middle-income […]

Medicines Patent Pool, drugmaker agreement set to expand access to new antiretroviral

By on .

Dolutegravir agreement continue collaboration between British company and Unitaid-launched treatment access organization With a high barrier to drug-resistance, low production costs, low dosing and a potential for pediatric use, the new HIV drug dolutegravir, approved by the U.S. Food and Drug Administration in August, and for use among adults and adolescents by the European Medicines […]

A column from Dr. Dybul, resolutions in Antigua, a court ruling in Zambia, and more . . . We’re reading about health & human rights

By on .

Better Health, Better Human Rights: The Global Fund to Fight AIDS, Tuberculosis and Malaria began with a commitment to advancing human rights in its fight against the diseases, Executive Director Mark Dybul notes, but the need to expand that focus becomes clearer as research confirms the effectiveness of focusing on the most vulnerable populations. This, […]

UNITAID Seeks Experts To Serve on Review Panel

By on .

UNITAID is looking for experts to serve on its Proposal Review Committee, an independent panel that provides technical advice and analysis of proposals for UNITAID funding. UNITAID was created to help scale up treatment for HIV/AIDS, malaria, and tuberculosis in resource-poor countries by leveraging lower prices for drugs and diagnostics and making those available items […]